126 related articles for article (PubMed ID: 38670554)
1. TNIK inhibition sensitizes TNIK-overexpressing lung squamous cell carcinoma to radiotherapy.
Nguyen T; Carrieri FA; Connis N; Lafargue A; Chang J; Chan A; Shetty AC; Song Y; Hoang T; Jagtap S; Chowdhury DD; Khan MA; Gabrielson KL; Rezaee M; Torres-Ayuso P; Brognard J; Hann CL; Tran PT
Mol Cancer Ther; 2024 Apr; ():. PubMed ID: 38670554
[TBL] [Abstract][Full Text] [Related]
2. TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy.
Nguyen T; Carrieri FA; Connis N; Lafargue A; Chang J; Chan A; Shetty AC; Song Y; Hoang T; Jagtap S; Chowdhury DD; Khan MA; Gabrielson KL; Rezaee M; Torres-Ayuso P; Brognard J; Hann CL; Tran PT
Mol Cancer Ther; 2024 Jun; ():OF1-OF11. PubMed ID: 38853421
[TBL] [Abstract][Full Text] [Related]
3. TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin.
Torres-Ayuso P; An E; Nyswaner KM; Bensen RC; Ritt DA; Specht SI; Das S; Andresson T; Cachau RE; Liang RJ; Ries AL; Robinson CM; Difilippantonio S; Gouker B; Bassel L; Karim BO; Miller CJ; Turk BE; Morrison DK; Brognard J
Cancer Discov; 2021 Jun; 11(6):1411-1423. PubMed ID: 33495197
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of Targeting Traf2-and-Nck-Interacting Kinase in Synovial Sarcoma.
Sekita T; Yamada T; Kobayashi E; Yoshida A; Hirozane T; Kawai A; Uno Y; Moriyama H; Sawa M; Nagakawa Y; Tsuchida A; Matsumoto M; Nakamura M; Nakayama R; Masuda M
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429395
[TBL] [Abstract][Full Text] [Related]
5. The Traf2 and NcK interacting kinase inhibitor NCB-0846 suppresses seizure activity involving the decrease of GRIA1.
Wang M; Gu Y; Li Q; Feng B; Lv X; Zhang H; Kong Q; Dong Z; Tian X; Zhang Y
Genes Dis; 2024 May; 11(3):100997. PubMed ID: 38292191
[TBL] [Abstract][Full Text] [Related]
6. Traf2 and NCK Interacting Kinase Is a Critical Regulator of Procollagen I Trafficking and Hepatic Fibrogenesis in Mice.
Buchl SC; Hanquier Z; Haak AJ; Thomason YM; Huebert RC; Shah VH; Maiers JL
Hepatol Commun; 2022 Mar; 6(3):593-609. PubMed ID: 34677004
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target.
Lee RS; Zhang L; Berger A; Lawrence MG; Song J; Niranjan B; Davies RG; Lister NL; Sandhu SK; Rubin MA; Risbridger GP; Taylor RA; Rickman DS; Horvath LG; Daly RJ
Neoplasia; 2019 Apr; 21(4):389-400. PubMed ID: 30901730
[TBL] [Abstract][Full Text] [Related]
8. Jatrorrhizine inhibits mammary carcinoma cells by targeting TNIK mediated Wnt/β-catenin signalling and epithelial-mesenchymal transition (EMT).
Sun Y; Gao X; Wu P; Wink M; Li J; Dian L; Liang Z
Phytomedicine; 2019 Oct; 63():153015. PubMed ID: 31302315
[TBL] [Abstract][Full Text] [Related]
9. TNIK inhibition abrogates colorectal cancer stemness.
Masuda M; Uno Y; Ohbayashi N; Ohata H; Mimata A; Kukimoto-Niino M; Moriyama H; Kashimoto S; Inoue T; Goto N; Okamoto K; Shirouzu M; Sawa M; Yamada T
Nat Commun; 2016 Aug; 7():12586. PubMed ID: 27562646
[TBL] [Abstract][Full Text] [Related]
10. Fbxo3-Dependent Fbxl2 Ubiquitination Mediates Neuropathic Allodynia through the TRAF2/TNIK/GluR1 Cascade.
Lin TB; Hsieh MC; Lai CY; Cheng JK; Chau YP; Ruan T; Chen GD; Peng HY
J Neurosci; 2015 Dec; 35(50):16545-60. PubMed ID: 26674878
[TBL] [Abstract][Full Text] [Related]
11. Traf2- and Nck-interacting kinase (TNIK) is involved in the anti-cancer mechanism of dovitinib in human multiple myeloma IM-9 cells.
Chon HJ; Lee Y; Bae KJ; Byun BJ; Kim SA; Kim J
Amino Acids; 2016 Jul; 48(7):1591-9. PubMed ID: 26995282
[TBL] [Abstract][Full Text] [Related]
12. The essential role of TNIK gene amplification in gastric cancer growth.
Yu DH; Zhang X; Wang H; Zhang L; Chen H; Hu M; Dong Z; Zhu G; Qian Z; Fan J; Su X; Xu Y; Zheng L; Dong H; Yin X; Ji Q; Ji J
Oncogenesis; 2014 Feb; 2(2):e89. PubMed ID: 24566388
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological blockage of transforming growth factor-β signalling by a Traf2- and Nck-interacting kinase inhibitor, NCB-0846.
Sugano T; Masuda M; Takeshita F; Motoi N; Hirozane T; Goto N; Kashimoto S; Uno Y; Moriyama H; Sawa M; Nagakawa Y; Tsuchida A; Seike M; Gemma A; Yamada T
Br J Cancer; 2021 Jan; 124(1):228-236. PubMed ID: 33244122
[TBL] [Abstract][Full Text] [Related]
14. Direct conversion of osteosarcoma to adipocytes by targeting TNIK.
Hirozane T; Masuda M; Sugano T; Sekita T; Goto N; Aoyama T; Sakagami T; Uno Y; Moriyama H; Sawa M; Asano N; Nakamura M; Matsumoto M; Nakayama R; Kondo T; Kawai A; Kobayashi E; Yamada T
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33400690
[TBL] [Abstract][Full Text] [Related]
15. Expression analysis of TRAF2‑ and NCK‑interacting protein kinase (TNIK) and phosphorylated TNIK in papillary thyroid carcinoma.
Li J; Lan L; Xu Y; Liu S; Liu M; Hu G; Wu G; Zhao Y; Shi J; Wang J; Sun Y; Wang Z; Zhao R
Oncol Lett; 2023 Jul; 26(1):310. PubMed ID: 37332335
[TBL] [Abstract][Full Text] [Related]
16. lncRNA ASBEL and lncRNA Erbb4-IR reduce chemoresistance against gemcitabine and cisplatin in stage IV lung squamous cell carcinoma via the microRNA-21/LZTFL1 axis.
Liang ZY; Zhang ZM; Sun GR; Zhao BS; Xin GH; Zhang L
Am J Cancer Res; 2023; 13(6):2732-2750. PubMed ID: 37424811
[TBL] [Abstract][Full Text] [Related]
17. TNIK in disease: from molecular insights to therapeutic prospects.
Wu X; Zhang Z; Qiu Z; Wu X; Chen J; Liu L; Liu X; Zhao S; Yang Y; Zhao Y
Apoptosis; 2024 Jun; ():. PubMed ID: 38853204
[TBL] [Abstract][Full Text] [Related]
18. The Traf2- and Nck-interacting kinase as a putative effector of Rap2 to regulate actin cytoskeleton.
Taira K; Umikawa M; Takei K; Myagmar BE; Shinzato M; Machida N; Uezato H; Nonaka S; Kariya K
J Biol Chem; 2004 Nov; 279(47):49488-96. PubMed ID: 15342639
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of traf2- and Nck-interacting kinase (TNIK) in polycystic ovary syndrome.
Li D; Jiao J; Zhou YM; Wang XX
Am J Transl Res; 2015; 7(6):1152-60. PubMed ID: 26279758
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy and chemotherapy in locally advanced non-small cell lung cancer: preclinical and early clinical data.
Reboul FL
Hematol Oncol Clin North Am; 2004 Feb; 18(1):41-53. PubMed ID: 15005280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
